Newsletter | February 13, 2026

02.13.26 -- Continuous Evidence Generation Remains Critical To Vaccine Development

SPONSOR

Join Clinical Leader Live Chief Editor Dan Schell on February 18, at 1pm Eastern, for this anticipated discussion on AI that will go beyond the buzzwords to focus on what’s actually working in clinical operations. You will hear about some of the newest real-world applications, lessons learned from early adopters, and how to spot hype before it costs you time or money. Register for free thanks to support from our sponsors.

TRIAL MONITORING

When "Imperfect" AI Models Still Add Value In Pharma Quality

AI isn't perfect, and that's OK, says ERA Science's Andy O'Connor. Here, he contends that if we can prove and explain how a human+AI process outperforms a human-only process, then imperfection is still progress.

Modernizing Clinical Trial Oversight: The Path To Operations Excellence

Examine the current state of RBQM approaches to virtualizing clinical oversight, and the value that adopting these approaches brings to sponsors, CROs, sites, and ultimately patients.

Technology To Enable Remote Participation

Secure, flexible virtual visits boost trial efficiency and patient engagement. Global reach, device integration, and intuitive scheduling reduce disruptions while ensuring compliance and data security.

CLINICAL DATA MANAGEMENT & ANALYTICS

Continuous Evidence Generation — Including RWE — Remains Critical To Vaccine Development

President of Takeda's Global Vaccine Business Unit Derek Wallace discusses the importance of continuous, real-world data collection in the context of vaccine development in low- and middle-income countries.

How Small Clinical Teams Can Adopt AI On A Tight Budget

Small clinical teams can adopt AI by starting with targeted use cases, leveraging cloud-based tools, and prioritizing data quality to improve efficiency and decision-making.

Putting Trial Data Insights Into Action For Your Study

Learn why sponsors should implement an integrated data monitoring plan and technology solution to ensure data integrity, meet evolving regulatory requirements, and improve trial outcomes.

Clinical Trials In The Age Of Cost Caps

On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

Agentic AI Is Transforming Life Sciences Discovery And Operations

73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.

Document Collaboration, Controlled

Streamline document reviews in life sciences with an innovative platform that ensures accuracy, compliance, and collaboration across teams for managing complex, high-stakes workflows efficiently.

The SaaS Clinical Data Science Platform

Streamline clinical data workflows and reduce the time spent preparing data for analytics with a comprehensive platform that enables the rapid delivery of clinical insights.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: